Literature DB >> 21842346

Regulation of arterial blood pressure by Akt1-dependent vascular relaxation.

Jung Min Ha1, Young Whan Kim, Dong Hyung Lee, Sung Ji Yun, Eun Kyoung Kim, In Hye Jin, Ji Hyun Kim, Chi Dae Kim, Hwa Kyoung Shin, Sun Sik Bae.   

Abstract

Endothelial cell-dependent vascular relaxation plays an important role in the regulation of blood pressure. Here, we show that stimulation of vascular endothelial cells with platelet-derived growth factor (PDGF) results in vascular relaxation through Akt1-dependent activation of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) production. Stimulation of both human umbilical artery endothelial cells and abdominal aortic vessels with PDGF induced NO production. PDGF-dependent production of NO was completely abolished by inhibition of phosphatidylinositol 3-kinase with wortmannin (100 nM). Stimulation of aortic vessels with PDGF resulted in the activation of Akt phosphorylation and eNOS phosphorylation: however, eNOS phosphorylation and production of NO were abolished in aortic vessels of mice lacking Akt1. PDGF strongly induced vascular relaxation in the presence of endothelium, and inhibition of NO production by N-nitro-L: -arginine-methyl ester completely blocked PDGF-dependent vascular relaxation. In addition, PDGF-dependent relaxation was completely abolished by inhibition of PI3K with wortmannin (100 nM). Furthermore, vessels from Akt1 heterozygotes showed normal relaxation after PDGF stimulation, whereas vessels from Akt1 knockout littermates did not respond to PDGF stimulation. Finally, administration of PDGF (5 ng/ml) significantly lowered blood pressure in Akt1 heterozygotes, whereas a blood pressure-lowering effect was not observed in Akt1 knockout littermates. These results suggest that Akt1 regulates blood pressure through regulation of vascular relaxation by eNOS phosphorylation and subsequent production of NO.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21842346     DOI: 10.1007/s00109-011-0798-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  Human vascular endothelial cells in culture. Lack of response to serum growth factors.

Authors:  C C Haudenschild; D Zahniser; J Folkman; M Klagsbrun
Journal:  Exp Cell Res       Date:  1976-03-01       Impact factor: 3.905

2.  Essential role of protein kinase B gamma (PKB gamma/Akt3) in postnatal brain development but not in glucose homeostasis.

Authors:  Oliver Tschopp; Zhong-Zhou Yang; Daniela Brodbeck; Bettina A Dummler; Maja Hemmings-Mieszczak; Takashi Watanabe; Thomas Michaelis; Jens Frahm; Brian A Hemmings
Journal:  Development       Date:  2005-06-01       Impact factor: 6.868

3.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

4.  Regulation of endothelium-derived nitric oxide production by the protein kinase Akt.

Authors:  D Fulton; J P Gratton; T J McCabe; J Fontana; Y Fujio; K Walsh; T F Franke; A Papapetropoulos; W C Sessa
Journal:  Nature       Date:  1999-06-10       Impact factor: 49.962

5.  The Akt kinase signals directly to endothelial nitric oxide synthase.

Authors:  B J Michell; J E Griffiths; K I Mitchelhill; I Rodriguez-Crespo; T Tiganis; S Bozinovski; P R de Montellano; B E Kemp; R B Pearson
Journal:  Curr Biol       Date:  1999 Jul 29-Aug 12       Impact factor: 10.834

6.  Human microvascular endothelial cells express receptors for platelet-derived growth factor.

Authors:  J G Beitz; I S Kim; P Calabresi; A R Frackelton
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-01       Impact factor: 11.205

7.  Thrombin and histamine stimulate endothelial nitric-oxide synthase phosphorylation at Ser1177 via an AMPK mediated pathway independent of PI3K-Akt.

Authors:  Brynhildur Thors; Haraldur Halldórsson; Gudmundur Thorgeirsson
Journal:  FEBS Lett       Date:  2004-08-27       Impact factor: 4.124

8.  Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension.

Authors:  N Selimovic; C-H Bergh; B Andersson; E Sakiniene; H Carlsten; B Rundqvist
Journal:  Eur Respir J       Date:  2009-03-26       Impact factor: 16.671

9.  Contribution of insulin and Akt1 signaling to endothelial nitric oxide synthase in the regulation of endothelial function and blood pressure.

Authors:  J David Symons; Shawna L McMillin; Christian Riehle; Jason Tanner; Milda Palionyte; Elaine Hillas; Deborah Jones; Robert C Cooksey; Morris J Birnbaum; Donald A McClain; Quan-Jiang Zhang; Derrick Gale; Lloyd J Wilson; E Dale Abel
Journal:  Circ Res       Date:  2009-04-02       Impact factor: 17.367

10.  Vasoconstriction: a new activity for platelet-derived growth factor.

Authors:  B C Berk; R W Alexander; T A Brock; M A Gimbrone; R C Webb
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

View more
  4 in total

Review 1.  Copanlisib for the Treatment of Malignant Lymphoma: Clinical Experience and Future Perspectives.

Authors:  Javier Munoz; George A Follows; Loretta J Nastoupil
Journal:  Target Oncol       Date:  2021-03-09       Impact factor: 4.493

2.  Analysis of extracellular superoxide dismutase and Akt in ascending aortic aneurysm with tricuspid or bicuspid aortic valve.

Authors:  A Arcucci; M R Ruocco; F Albano; G Granato; V Romano; G Corso; C Bancone; E De Vendittis; A Della Corte; S Montagnani
Journal:  Eur J Histochem       Date:  2014-07-18       Impact factor: 3.188

3.  First-in-human phase I study of copanlisib (BAY 80-6946), an intravenous pan-class I phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors and non-Hodgkin's lymphomas.

Authors:  A Patnaik; L J Appleman; A W Tolcher; K P Papadopoulos; M Beeram; D W Rasco; G J Weiss; J C Sachdev; M Chadha; M Fulk; S Ejadi; J M Mountz; M T Lotze; F G S Toledo; E Chu; M Jeffers; C Peña; C Xia; S Reif; I Genvresse; R K Ramanathan
Journal:  Ann Oncol       Date:  2016-10       Impact factor: 32.976

4.  Endothelial CaMKII as a regulator of eNOS activity and NO-mediated vasoreactivity.

Authors:  Shubha Murthy; Olha M Koval; Juan M Ramiro Diaz; Santosh Kumar; Daniel Nuno; Jason A Scott; Chantal Allamargot; Linda J Zhu; Kim Broadhurst; Velarchana Santhana; William J Kutschke; Kaikobad Irani; Kathryn G Lamping; Isabella M Grumbach
Journal:  PLoS One       Date:  2017-10-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.